Characterization of antibody response in neuroinvasive infection caused by Toscana virus
A. Pierro(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Stefania Varani(University of Bologna), Luigi Raumer(University of Bologna), Francesca Prati(University of Modena and Reggio Emilia), Vittorio Sambri(Azienda Unità Sanitaria Locale Della Romagna), Simona Schivazappa, Silvia Morini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), P. Cenni, S. Ficarelli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Rémi N. Charrel(Centre National de la Recherche Scientifique), Russell E. Lewis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Nazlı Ayhan(Inserm), Antonio Mastroianni(Azienda Ospedaliera di Cosenza), Michele Bartoletti(University of Bologna), Caterina Vocale(Azienda USL di Bologna), M.P. Landini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Giada Rossini(Azienda USL di Bologna), Paolo Gaibani(University of Verona)
Cited by 26
Related Papers
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
|Clinical Microbiology and Infection|2018|1.5k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide
|Gastroenterology|2018|513
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
|Intensive Care Medicine|2020|464